Between 2015 and 2023, Japan led Asia in the number of novel drug approvals granted by the US Food and Drug Administration (FDA). According to recent data from McKinsey & Company, Japan secured a total of 24 novel drug approvals during this period. This achievement highlights Japan’s significant position in the pharmaceutical industry within Asia and underscores its role in advancing innovative drug development.
About The Author
